<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Aging Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Aging Cell</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1474-9726</journal-id>
<journal-id journal-id-type="publisher-id">ACEL</journal-id>
<journal-title-group>
<journal-title>Aging Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1474-9718</issn>
<issn pub-type="epub">1474-9726</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30051577</article-id>
<article-id pub-id-type="pmc">6156544</article-id>
<article-id pub-id-type="doi">10.1111/acel.12820</article-id>
<article-id pub-id-type="publisher-id">ACEL12820</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Paper</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased transport of acetyl‐CoA into the endoplasmic reticulum causes a progeria‐like phenotype</article-title>
<alt-title alt-title-type="left-running-head">PENG et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="acel12820-cr-0001">
<name>
<surname>Peng</surname>
<given-names>Yajing</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0002">
<name>
<surname>Shapiro</surname>
<given-names>Samantha L.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0003">
<name>
<surname>Banduseela</surname>
<given-names>Varuna C.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acel12820-curr-0001">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0004">
<name>
<surname>Dieterich</surname>
<given-names>Inca A.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0005">
<name>
<surname>Hewitt</surname>
<given-names>Kyle J.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0006">
<name>
<surname>Bresnick</surname>
<given-names>Emery H.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0007">
<name>
<surname>Kong</surname>
<given-names>Guangyao</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0008">
<name>
<surname>Zhang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0009">
<name>
<surname>Schueler</surname>
<given-names>Kathryn L.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0010">
<name>
<surname>Keller</surname>
<given-names>Mark P.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0011">
<name>
<surname>Attie</surname>
<given-names>Alan D.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0012">
<name>
<surname>Hacker</surname>
<given-names>Timothy A.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0013">
<name>
<surname>Sullivan</surname>
<given-names>Ruth</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0007">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0014">
<name>
<surname>Kielar‐Grevstad</surname>
<given-names>Elle</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0015">
<name>
<surname>Arriola Apelo</surname>
<given-names>Sebastian I.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-curr-0002">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0016">
<name>
<surname>Lamming</surname>
<given-names>Dudley W.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="acel12820-cr-0017">
<name>
<surname>Anderson</surname>
<given-names>Rozalyn M.</given-names>
</name>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0008">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="acel12820-cr-0018">
<name>
<surname>Puglielli</surname>
<given-names>Luigi</given-names>
</name>
<address>
<email>lp1@medicine.wisc.edu</email>
</address>
<xref ref-type="aff" rid="acel12820-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0008">
<sup>8</sup>
</xref>
<xref ref-type="aff" rid="acel12820-aff-0009">
<sup>9</sup>
</xref>
</contrib>
</contrib-group>
<aff id="acel12820-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Waisman Center</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Neuroscience Training Program</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Cell and Regenerative Biology</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Biochemistry</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Cardiovascular Research Center</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Department of Comparative Biosciences</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Geriatric Research Education Clinical Center</named-content>
<institution>Veterans Affairs Medical Center</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Department of Neuroscience</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<aff id="acel12820-curr-0001"><label><sup>10</sup></label>Present address:
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>University of Michigan</institution>
<named-content content-type="city">Ann Arbor</named-content>
<named-content content-type="country-part">Michigan</named-content>
</aff>
<aff id="acel12820-curr-0002"><label><sup>11</sup></label>Present address:
<named-content content-type="organisation-division">Department of Dairy Science</named-content>
<institution>University of Wisconsin‐Madison</institution>
<named-content content-type="city">Madison</named-content>
<named-content content-type="country-part">Wisconsin</named-content>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Luigi Puglielli, University of Wisconsin‐Madison, Waisman Center, 1500 Highland Ave, Madison, WI 53705.<break></break>
Email: <email>lp1@medicine.wisc.edu</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<volume>17</volume>
<issue>5</issue>
<issue-id pub-id-type="doi">10.1111/acel.2018.17.issue-5</issue-id>
<elocation-id>e12820</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 The Anatomical Society and John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Aging Cell</italic> published by the Anatomical Society and John Wiley &amp; Sons Ltd.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:ACEL-17-e12820.pdf" xlink:type="simple"></self-uri>
<abstract id="acel12820-abs-0001">
<title>Abstract</title>
<p>The membrane transporter AT‐1/SLC33A1 translocates cytosolic acetyl‐CoA into the lumen of the endoplasmic reticulum (ER), participating in quality control mechanisms within the secretory pathway. Mutations and duplication events in <italic>AT‐1/SLC33A1</italic> are highly pleiotropic and have been linked to diseases such as spastic paraplegia, developmental delay, autism spectrum disorder, intellectual disability, propensity to seizures, and dysmorphism. Despite these known associations, the biology of this key transporter is only beginning to be uncovered. Here, we show that systemic overexpression of AT‐1 in the mouse leads to a segmental form of progeria with dysmorphism and metabolic alterations. The phenotype includes delayed growth, short lifespan, alopecia, skin lesions, rectal prolapse, osteoporosis, cardiomegaly, muscle atrophy, reduced fertility, and anemia. In terms of homeostasis, the AT‐1 overexpressing mouse displays hypocholesterolemia, altered glycemia, and increased indices of systemic inflammation. Mechanistically, the phenotype is caused by a block in Atg9a‐Fam134b‐LC3β and Atg9a‐Sec62‐LC3β interactions, and defective reticulophagy, the autophagic recycling of the ER. Inhibition of ATase1/ATase2 acetyltransferase enzymes downstream of AT‐1 restores reticulophagy and rescues the phenotype of the animals. These data suggest that inappropriately elevated acetyl‐CoA flux into the ER directly induces defects in autophagy and recycling of subcellular structures and that this diversion of acetyl‐CoA from cytosol to ER is causal in the progeria phenotype. Collectively, these data establish the cytosol‐to‐ER flux of acetyl‐CoA as a novel event that dictates the pace of aging phenotypes and identify intracellular acetyl‐CoA‐dependent homeostatic mechanisms linked to metabolism and inflammation.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="acel12820-kwd-0001">acetyl‐CoA</kwd>
<kwd id="acel12820-kwd-0002">AT‐1/SLC33A1</kwd>
<kwd id="acel12820-kwd-0003">ATase1</kwd>
<kwd id="acel12820-kwd-0004">ATase2</kwd>
<kwd id="acel12820-kwd-0005">lysine acetylation</kwd>
<kwd id="acel12820-kwd-0006">progeria</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>NIH</funding-source>
<award-id>NS094154</award-id>
<award-id>AG053937</award-id>
<award-id>AG057408</award-id>
<award-id>DK50107</award-id>
<award-id>HL113066</award-id>
<award-id>CA152108</award-id>
<award-id>DK102948</award-id>
<award-id>DK108259</award-id>
<award-id>AG041765</award-id>
<award-id>AG051974</award-id>
</award-group>
<award-group>
<funding-source>Waisman Center</funding-source>
<award-id>NICHD‐U54 HD090256</award-id>
</award-group>
<award-group>
<funding-source>American Federation for Aging Research</funding-source>
<award-id>T32 AG000213</award-id>
</award-group>
<award-group>
<funding-source>American Diabetes Association</funding-source>
</award-group>
<award-group>
<funding-source>Core</funding-source>
</award-group>
<award-group>
<funding-source>University of Wisconsin‐Madison</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="1"></table-count>
<page-count count="17"></page-count>
<word-count count="32467"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>acel12820</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>October 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.9 mode:remove_FC converted:26.09.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="acel12820-cit-1001" publication-type="journal">
<string-name>
<surname>Peng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shapiro</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Banduseela</surname>
<given-names>VC</given-names>
</string-name>, et al. <article-title>Increased transport of acetyl‐CoA into the endoplasmic reticulum causes a progeria‐like phenotype</article-title>. <source xml:lang="en"/>Aging Cell. <year>2018</year>;<volume>17</volume>:<elocation-id>e12820</elocation-id>
<pub-id pub-id-type="doi">10.1111/acel.12820</pub-id>
</mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="acel12820-sec-0001">
<label>1</label>
<title>INTRODUCTION</title>
<p>Nε‐lysine acetylation in the lumen of the endoplasmic reticulum (ER) has emerged as a novel mechanism for the regulation of protein homeostasis (also referred to as proteostasis) within the organelle (Ding, Dellisanti, Ko, Czajkowski, &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0004">2014</xref>; Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>; Jonas, Pehar, &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0016">2010</xref>; Pehar, Jonas, Hare, &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>, <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). Acetylation of ER cargo proteins is ensured by three essential elements: AT‐1, ATase1, and ATase2. AT‐1 (also referred to as SLC33A1) is the ER membrane transporter that regulates the cytosol‐to‐ER flux of acetyl‐CoA, donor of the acetyl group in the reaction of Nε‐lysine acetylation (Jonas et al., <xref ref-type="ref" rid="acel12820-bib-0016">2010</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). ATase1 (also referred to as NAT8B) and ATase2 (also referred to as NAT8) are type II ER membrane proteins that carry out the reaction of Nε‐lysine acetylation within the ER lumen (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0004">2014</xref>; Ko &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0023">2009</xref>). Ex vivo and in vivo data suggest that the ER acetylation machinery is a component of ER quality control and regulates two essential functions of the organelle: (a) selection and transport of cargo proteins along the secretory pathway; and (b) disposal of protein aggregates that form within the ER and secretory pathway (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0004">2014</xref>; Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>; Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>, <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). The former requires the ATases to associate with the oligosaccharyltransferase complex (OST) and acetylate correctly folded polypeptides (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0004">2014</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>) while the latter requires acetylation/deacetylation of the autophagy protein Atg9a (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>, <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref> ). AT‐1 regulates availability of acetyl‐CoA within the ER; as such, it plays crucial regulatory functions for the entire ER acetylation machinery.</p>
<p>Clinically, diverse outcomes related to genetic deficiency, mutation, or overabundance of AT‐1 have been identified. Children with homozygous mutations in <italic>AT‐1/SLC33A1</italic> display congenital defects, severe developmental delay, and premature death (Chiplunkar et al., <xref ref-type="ref" rid="acel12820-bib-0002">2016</xref>; Huppke et al., <xref ref-type="ref" rid="acel12820-bib-0014">2012</xref>). Patients with heterozygous mutations appear normal at birth but then develop a complicated autosomal dominant form of spastic paraplegia (Lin et al., <xref ref-type="ref" rid="acel12820-bib-0030">2008</xref>). Finally, chromosomal duplications of the 3q25.31 locus, which harbors <italic>AT‐1/SLC33A1</italic>, have been reported in patients with autism spectrum disorder (ASD), intellectual disability, propensity to seizures, and facial dysmorphism (SFARI database; see also Swisshelm et al. 2014. ASHG Annual Meeting; Abstract 3205 T). The above disease phenotypes are mimicked by related mouse models. Knock‐in mice that lack AT‐1 activity (AT‐1<sup>S113R/S113R</sup>) die during embryogenesis, while mice with haploinsufficiency of AT‐1 (AT‐1<sup>S113R/+</sup>) develop neurodegeneration with spasticity and propensity to infections and cancer (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). Transgenic mice that overexpress AT‐1 in forebrain neurons (AT‐1 Tg) display an ASD‐like phenotype without dysmorphism (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>). Mechanistically, the phenotype of AT‐1<sup>S113R/+</sup> mice is linked to aberrant activation of autophagy (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>) while the phenotype of AT‐1 Tg is linked to increased efficiency of the secretory pathway (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>). When taken together, the convergence of human‐ and mouse‐based studies clearly indicates that the ER acetylation machinery plays fundamental biological functions.</p>
<p>Despite these known associations, the biology of AT‐1 and the ER acetylation machinery is only beginning to be uncovered. Here, we sought to investigate the broader consequences of AT‐1 manipulation, including the cellular and systemic impact of AT‐1‐directed changes in ER acetylation, by generating a transgenic mouse where AT‐1 was placed under the control of the Rosa26 locus. The animals developed a severe phenotype mimicking segmental forms of human progerias. At a mechanistic level, we observed increased acetylation of the ER‐localized autophagy protein Atg9a, reduced Atg9a‐Fam134b‐LC3β and Atg9a‐Sec62‐LC3β interaction, and a block in ER‐autophagy/reticulophagy. Finally, we showed that a specific ATase1/ATase2 inhibitor, which restores ER proteostatic functions downstream of AT‐1, was able to rescue the entire phenotype of the animals, including the lifespan. Collectively, these data establish the cytosol‐to‐ER flux of acetyl‐CoA as a novel event that dictates the pace of aging phenotypes and identify intracellular acetyl‐CoA‐dependent homeostatic mechanisms linked to metabolism and inflammation.</p>
</sec>
<sec id="acel12820-sec-0002">
<label>2</label>
<title>RESULTS</title>
<sec id="acel12820-sec-0003">
<label>2.1</label>
<title>AT‐1 sTg mice display a progeria‐like phenotype</title>
<p>To study the systemic role of AT‐1, we generated transgenic (Tg) mice with an inducible overexpression Tet‐Off system driven by the Rosa26 locus (Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>a,b). For the purpose of this study, the animals (referred to as AT‐1 sTg) were maintained in the absence of doxycycline (Dox); therefore, they overexpressed AT‐1 throughout their entire life, including development. The animals were born with Mendelian ratio and were completely normal at birth. However, within 1 month they appeared smaller than their wild‐type/non‐Tg (WT) littermates (Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>c), and within 2 months they displayed a severe phenotype (Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>c and Table <xref ref-type="table" rid="acel12820-tbl-0001">1</xref>) that was reminiscent of segmental forms of human progerias (Gonzalo, Kreienkamp, &amp; Askjaer, <xref ref-type="ref" rid="acel12820-bib-0011">2017</xref>; Karikkineth, Scheibye‐Knudsen, Fivenson, Croteau, &amp; Bohr, <xref ref-type="ref" rid="acel12820-bib-0018">2017</xref>; Liao &amp; Kennedy, <xref ref-type="ref" rid="acel12820-bib-0029">2014</xref>; Pivnick et al., <xref ref-type="ref" rid="acel12820-bib-0045">2000</xref>). Indeed, they remained smaller throughout their entire lifespan (Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>d), appeared phenotypically old (Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>c), and displayed a very short lifespan (Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>e). The progeria‐like features of the animals are listed in Table <xref ref-type="table" rid="acel12820-tbl-0001">1</xref>.</p>
<fig fig-type="Figure" id="acel12820-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>AT‐1 sTg mice are smaller and have a short lifespan. (a) AT‐1 sTg mice were generated with an inducible Tet‐Off expression system under the control of the Rosa26 locus for systemic overexpression. (b) Western blots showing AT‐1 overexpression in different tissues (<italic>1</italic>, WT; <italic>2</italic>, AT‐1 sTg). (c) Representative AT‐1 sTg mouse and WT littermate when 28 and 55 days old. (d) Body weight of male and female WT and AT‐1 sTg mice across their lifespan. (e) Lifespan of AT‐1 sTg mice (<italic>maximum lifespan</italic>, males = 142 days, females = 147 days, <italic>p</italic> &lt; 0.0005; <italic>median lifespan</italic>, males = 96 days, females = 81 days, <italic>p</italic> &lt; 0.0005). Bars represent mean ± <italic>SD</italic>. <sup>*</sup>
<italic>p</italic> &lt; 0.05; <sup>**</sup>
<italic>p</italic> &lt; 0.005; <sup>#</sup>
<italic>p</italic> &lt; 0.0005</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="ACEL-17-e12820-g001"></graphic>
</fig>
<table-wrap id="acel12820-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Observed phenotype of AT‐1 sTg mice</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Median lifespan</td>
<td align="left" colspan="1" rowspan="1">Greatly reduced (males, 96 days; females, 81 days)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Maximum lifespan</td>
<td align="left" colspan="1" rowspan="1">Greatly reduced (males, 142 days; females, 147 days)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Body weight</td>
<td align="left" colspan="1" rowspan="1">Reduced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dysmorphism</td>
<td align="left" colspan="1" rowspan="1">Observed</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Major organ mass</td>
<td align="left" colspan="1" rowspan="1">Increased (exception: uterus, decreased)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fertility</td>
<td align="left" colspan="1" rowspan="1">Males, normal; females, reduced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Adipose tissue</td>
<td align="left" colspan="1" rowspan="1">Reduced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lordokyphosis</td>
<td align="left" colspan="1" rowspan="1">Modest or absent</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cardiomegaly</td>
<td align="left" colspan="1" rowspan="1">Pronounced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Osteoporosis</td>
<td align="left" colspan="1" rowspan="1">Pronounced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hair loss</td>
<td align="left" colspan="1" rowspan="1">Pronounced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hair regrowth</td>
<td align="left" colspan="1" rowspan="1">Greatly reduced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Skin lesions</td>
<td align="left" colspan="1" rowspan="1">Pronounced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Wound repair</td>
<td align="left" colspan="1" rowspan="1">Retarded</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Muscle atrophy</td>
<td align="left" colspan="1" rowspan="1">Modest to severe</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cataracts</td>
<td align="left" colspan="1" rowspan="1">Normal (as in WT)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dermal thickness</td>
<td align="left" colspan="1" rowspan="1">Reduced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Rectal prolapse</td>
<td align="left" colspan="1" rowspan="1">Common</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Systemic inflammation</td>
<td align="left" colspan="1" rowspan="1">Pronounced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peripheral WBC</td>
<td align="left" colspan="1" rowspan="1">Altered (B cell and neutrophil expansion)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peripheral RBC</td>
<td align="left" colspan="1" rowspan="1">Altered (anemia)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Serum glucose/insulin</td>
<td align="left" colspan="1" rowspan="1">Reduced</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Serum lipids</td>
<td align="left" colspan="1" rowspan="1">Hypocholesterolemia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glucose tolerance</td>
<td align="left" colspan="1" rowspan="1">Altered</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In addition to being small, AT‐1 sTg mice were very thin and had small fat pads (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>a,b); the significant reduction in fat tissue was observed despite the fact that they ate more than their WT littermates (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>c). AT‐1 sTg mice also displayed small areas of muscle atrophy (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>d). However, relative to their body weight, they had overall enlarged organs (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>e); the only exception was the uterus, which appeared significantly smaller and atrophic (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>e; see Inset). This finding is in line with the observed reduced fertility of female animals (Table <xref ref-type="table" rid="acel12820-tbl-0001">1</xref>). The skin displayed hair loss, multiple lesions, and delayed wound repair (Figures <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>c and <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>f; Table <xref ref-type="table" rid="acel12820-tbl-0001">1</xref>). Histologically, we observed dermatitis with marked acanthosis and moderate orthokeratotic hyperkeratosis, reactive fibrosis, and epidermal hyperplasia (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>g). Most of the animals also developed rectal prolapse (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>f). Both male and female AT‐1 sTg mice displayed severe bone density loss, which was reminiscent of human osteoporosis (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>h–j). In line with the postmortem data (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>e), echocardiographic assessment of living animals confirmed that AT‐1 sTg mice suffered from cardiomegaly very early in life (Figure <xref ref-type="fig" rid="acel12820-fig-0002">2</xref>k,l).</p>
<fig fig-type="Figure" id="acel12820-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>AT‐1 sTg mice display progeria‐like features. (a) Examination of WT and AT‐1 sTg mice. Reduced fat accumulation and splenomegaly are evident in both AT‐1 sTg males and females. (b) Total body fat in WT and AT‐1 sTg mice as determined by dual‐energy X‐ray (DEXA) scanning (males, <italic>n</italic> = 7; females, <italic>n</italic> = 8). (c) Food intake of WT and AT‐1 sTg mice (males, <italic>n</italic> = 5; females, <italic>n</italic> = 5). (d) Skeletal muscle histology. (e) Weight of major organs. <italic>Inset</italic> shows uterus. (f) Skin alterations and rectal prolapse in AT‐1 sTg mice. (g) H&amp;E staining of a skin section from AT‐1 sTg mice. (h, i) Faxitron X‐ray (femur) (h) and bone mineral density (i) of WT and AT‐1 sTg mice (WT, <italic>n</italic> = 8; AT‐1 sTg, <italic>n</italic> = 8). (j) Goldner's trichrome stain of femur sections. (k, l) Echocardiographic assessment of WT and AT‐1 sTg mice (WT, <italic>n</italic> = 8; AT‐1 sTg, <italic>n</italic> = 8). Bars represent mean ± <italic>SD</italic>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.005, <sup>#</sup>
<italic>p</italic> &lt; 0.0005. LVID<italic>: d</italic>, left ventricular internal diameter end diastole; LVPW<italic>: d</italic>, left ventricular posterior wall end diastole; LVAW<italic>: d</italic>, left ventricular anterior wall end diastole</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="ACEL-17-e12820-g002"></graphic>
</fig>
</sec>
<sec id="acel12820-sec-0004">
<label>2.2</label>
<title>AT‐1 sTg mice display defective hematopoiesis, metabolic alterations, and systemic inflammation</title>
<p>A complete blood count of AT‐1 sTg mice revealed mild‐to‐moderate anemia, which was well evident in females (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>a). The anemia was accompanied by splenomegaly and expansion of the spleen interfollicular/red pulp (extramedullary hematopoiesis) in both males and females (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>b). We also observed reduced levels of circulating ferritin (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S1</xref>a) and iron (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S1</xref>b), increased reticulocyte ratio in the peripheral blood (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>c), and reduced erythrocyte/nucleated ratio in the bone marrow (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>d). Further assessment revealed a marked increase in erythroid progenitor activity in AT‐1 sTg spleens relative to WT (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>e,f). When taken together, the above results indicate that AT‐1 overexpression disrupts steady‐state hematopoiesis, causing splenomegaly and extramedullary erythropoiesis.</p>
<fig fig-type="Figure" id="acel12820-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>AT‐1 sTg mice display defective hematopoiesis, and reduced levels of circulating glucose, insulin, and cholesterol. (a) Hematologic parameters of WT and AT‐1 sTg mice (males, <italic>n</italic> = 4; females, <italic>n</italic> = 6). (b) Representative images of whole spleen from WT and AT‐1 sTg mice. (c, d) Quantitative blood (c) and bone marrow (d) smears in WT and AT‐1 sTg mice (males, <italic>n</italic> = 4; females, <italic>n</italic> = 4). (e) Quantitation (left) and representative images (right) of colony‐forming unit‐erythroid (CFU‐E) colonies 2 days after plating splenic cells (1 × 10<sup>5</sup>) from WT (<italic>n</italic> = 3) and AT‐1 sTg (<italic>n</italic> = 3) mice in methylcellulose containing Epo, SCF, IL‐3, and IL‐6. (f) Quantitation (left) and representative images (right) of burst‐forming unit‐erythroid (BFU‐E) colonies 5 days after plating splenic cells (1 × 10<sup>5</sup>) from WT (<italic>n</italic> = 3) and AT‐1 sTg (<italic>n</italic> = 3) mice in methylcellulose containing Epo, SCF, IL‐3, and IL‐6. (g, h) Fasting levels of glucose (g) and insulin (h) in plasma (males, <italic>n</italic> = 5; females, <italic>n</italic> = 5). (i, j) Oral glucose tolerance test (OGTT) in WT and AT‐1 sTg mice (males, <italic>n</italic> = 5; females, <italic>n</italic> = 5). AUC<sub>glucose</sub> (i) and AUC<sub>insulin</sub> (j) are shown. (k) Plasma lipid profile in WT and AT‐1 sTg mice (males, <italic>n</italic> = 5; females, <italic>n</italic> = 5). Bars represent mean ± <italic>SD</italic>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.005, <sup>#</sup>
<italic>p</italic> &lt; 0.0005. WBC<italic>:</italic> white blood cells; RBC: red blood cells; HCT: hematocrit; Hb: hemoglobin. WBC<italic>:</italic> white blood cells; RBC: red blood cells; HCT: hematocrit; Hb: hemoglobin</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="ACEL-17-e12820-g003"></graphic>
</fig>
<p>Metabolic assessment of AT‐1 sTg mice revealed reduced levels of circulating glucose and insulin (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>g,h) but normal levels of glucagon (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S2</xref>a). Lower levels of plasma glucose and insulin were also observed following an oral glucose tolerance test (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>i,j and Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S2</xref>b,c) suggesting a more effective utilization of glucose. The metabolic assessment of the animals also revealed reduced levels of circulating cholesterol (Figure <xref ref-type="fig" rid="acel12820-fig-0003">3</xref>k).</p>
<p>Postmortem examination of AT‐1 sTg mice revealed enlarged lymph nodes (Figure <xref ref-type="fig" rid="acel12820-fig-0004">4</xref>a) as well as histological evidence for moderate inflammatory infiltration across different tissues and organs, indicative of systemic inflammation. Consistently, we observed increased levels of several inflammatory molecules in the plasma (Figure <xref ref-type="fig" rid="acel12820-fig-0004">4</xref>b) as well as a marked immunoglobulin infiltration of peripheral tissues (Figure <xref ref-type="fig" rid="acel12820-fig-0004">4</xref>c–f). The increased systemic inflammation in AT‐1 sTg mice was also reflected in the significant increase in B cells and neutrophils in the peripheral blood relative to WT (Figure <xref ref-type="fig" rid="acel12820-fig-0004">4</xref>g,h). Chronic tissue inflammation is often associated with markers of cellular senescence (Jeon et al., <xref ref-type="ref" rid="acel12820-bib-0015">2017</xref>; Kang et al., <xref ref-type="ref" rid="acel12820-bib-0017">2015</xref>; Ovadya &amp; Krizhanovsky, <xref ref-type="ref" rid="acel12820-bib-0038">2014</xref>; Tchkonia, Zhu, Deursen, Campisi, &amp; Kirkland, <xref ref-type="ref" rid="acel12820-bib-0050">2013</xref>). Therefore, we used isolated hepatocytes and liver sections to determine levels of p16, p21, and senescence‐associated β‐galactosidase (SA‐β‐Gal), three established markers of cell senescence (Jeon et al., <xref ref-type="ref" rid="acel12820-bib-0015">2017</xref>; Kang et al., <xref ref-type="ref" rid="acel12820-bib-0017">2015</xref>; Ovadya &amp; Krizhanovsky, <xref ref-type="ref" rid="acel12820-bib-0038">2014</xref>; Tchkonia et al., <xref ref-type="ref" rid="acel12820-bib-0050">2013</xref>). We consistently found increased levels of the senescent markers in AT‐1 sTg mice when compared to WT littermates (Figure <xref ref-type="fig" rid="acel12820-fig-0004">4</xref>i–l). These results were paralleled by a significant reduction in the proliferation potential of mouse embryonic fibroblasts (MEF) in culture (Figure <xref ref-type="fig" rid="acel12820-fig-0004">4</xref>m,n).</p>
<fig fig-type="Figure" id="acel12820-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>AT‐1 sTg mice display systemic and tissue inflammation. (a) Weight of axillary lymph nodes in WT and AT‐1 sTg mice (<italic>n</italic> = 6 per group). (b) Plasma inflammatory markers (out of a total of 42 different analytes tested). In red, analytes that were changed in both males and females (males, <italic>n</italic> = 6; females, <italic>n</italic> = 6). (c, d) Dot blot of tissue immunoglobulins determined with anti‐mouse IgG. Representative images (c) and quantitation of results (d) are shown. The analysis was carried out in liver (WT, <italic>n</italic> = 3; AT‐1 sTg, <italic>n</italic> = 3). (e, f) Western blot showing tissue immunoglobulins determined with anti‐mouse IgG. Representative images (e) and quantitation of results (f) are shown. The analysis was carried out in liver (WT, <italic>n</italic> = 3; AT‐1 sTg, <italic>n</italic> = 3). (g, h) Flow cytometry showing B cell (g), and neutrophil (h) population in bone marrow and peripheral blood (WT, <italic>n</italic> = 3; AT‐1 sTg, <italic>n</italic> = 3). (i) Western blot showing p16 levels in liver. Representative images (left panel) and quantitation of results (right panel) are shown (WT, <italic>n</italic> = 7; AT‐1 sTg, <italic>n</italic> = 7). (j) p21 mRNA quantitation in liver (WT, <italic>n</italic> = 7; AT‐1 sTg, <italic>n</italic> = 7). (k, l) SA‐β‐Gal staining in liver and hepatocytes. Representative images (k) and quantitation of results (l) are shown (WT, <italic>n</italic> = 3; AT‐1 sTg, <italic>n</italic> = 3). (m, n) Proliferation potential of cultured MEF expressed as proliferation rate at each passage (m; <italic>n</italic> = 3 different MEF lines/group) and as cell number after plating (n; <italic>n</italic> = 3 different MEF lines/group). Bars represent mean ± <italic>SD</italic>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.005, <sup>#</sup>
<italic>p</italic> &lt; 0.0005. EC: extracellular; FA: formic acid‐soluble; Hc: heavy chain; IC: intracellular; Lc: light chain; MB: membrane‐bound</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="ACEL-17-e12820-g004"></graphic>
</fig>
</sec>
<sec id="acel12820-sec-0005">
<label>2.3</label>
<title>AT‐1 sTg mice display defective reticulophagy</title>
<p>The above results indicate that systemic overexpression of AT‐1 causes a complex phenotype that resembles human segmental progerias with metabolic alterations. We previously reported that the influx of acetyl‐CoA from the cytosol to the ER lumen by AT‐1 regulates the induction of ER‐autophagy and the disposal of protein aggregates within the secretory pathway (Jonas et al., <xref ref-type="ref" rid="acel12820-bib-0016">2010</xref>; Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>, <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref> ). Therefore, it is possible that a defect in ER‐autophagy (also referred to as reticulophagy) is at the basis of the progeria‐like phenotype of AT‐1 sTg mice.</p>
<p>To test the above hypothesis, we first analyzed the acetylation profile of the autophagy protein Atg9a, which is essential for the induction of autophagy downstream of the ER acetylation machinery (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>, <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref> ). In fact, Atg9a undergoes acetylation on two lysine residues, K359 and K363, which face the lumen of the ER (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>). Acetylated Atg9a blocks the induction of autophagy while nonacetylated Atg9a exerts the opposite effect (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>). Direct assessment of ER membranes from WT and AT‐1 sTg mice revealed a marked increase in the acetylation status of Atg9a in the transgenic animals (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>a,b), thus supporting our hypothesis. To assess whether the increased acetylation of Atg9a was accompanied by reduced disposal of misfolded/aggregated ER cargo proteins, we took advantage of the pro‐aggregating properties of the A53 T mutant form of α‐synuclein (A53 T syn; Polymeropoulos et al., <xref ref-type="ref" rid="acel12820-bib-0046">1997</xref>). Specifically, we used A53 T syn with a signal peptide (SP) at the N‐terminus to direct translation on the ER and insertion into the secretory pathway (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). The results show that when expressed in MEF, the levels of aggregated/SDS soluble SP‐A53 T syn were higher in AT‐1 sTg vs. WT animals (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S3</xref>a,b). This finding is consistent with previous data, where we showed a more efficient clearance of SP‐A53 T syn in MEF from AT‐1<sup>S113R/+</sup> mice, which display reduced AT‐1 activity, reduced acetylation of Atg9a, and increased induction of ER‐autophagy (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). Therefore, when taken together, data from two different animal models, AT‐1 sTg (present study) and AT‐1<sup>S113R/+</sup> (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>) mice, as well as cellular systems (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>), support the conclusion that the increased acetylation of Atg9a in AT‐1 sTg mice is causally linked to reduced ability of the ER to dispose of toxic protein aggregates that form within its lumen (see also later).</p>
<fig fig-type="Figure" id="acel12820-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<p>AT‐1 sTg mice display defective reticulophagy and expansion of the ER. (a, b) Western blot showing levels of acetylated‐Atg9a (Atg9a‐Ac) in ER preparations from liver. Representative blots are shown in (a) while quantitation of results is shown in (b) (WT, <italic>n</italic> = 3; AT‐1 sTg, <italic>n</italic> = 3). (c) Structure illumination microscopy (SIM) of ER in isolated hepatocytes showing size and morphology of sheet‐like structures. (d, e) SIM showing Fam134b puncta on ER of isolated hepatocytes. Quantitation of results is shown in (e) (WT, <italic>n</italic> = 8; AT‐1 sTg, <italic>n</italic> = 7). (f) Fam134b mRNA quantitation in liver (WT, <italic>n</italic> = 6; AT‐1 sTg, <italic>n</italic> = 5). (g, h) Western blot showing levels of Fam134b in ER preparations. Representative blots are shown in (g) while quantitation of results is shown in (h) (WT, <italic>n</italic> = 4; AT‐1 sTg, <italic>n</italic> = 4). (i, j) SIM showing reduced Fam134b/LC3β co‐localization on ER of isolated hepatocytes from AT‐1 sTg mice. Quantitation of results is shown in (j) (WT, <italic>n</italic> = 5; AT‐1 sTg, <italic>n</italic> = 5). (k, l) Western blot showing co‐immunoprecipitation of Atg9a and Fam134b in WT and AT‐1 sTg mice. Representative blots are shown in (k) while quantitation of results is shown in (l) (WT, <italic>n</italic> = 8; AT‐1 sTg, <italic>n</italic> = 8). (m, n) SIM showing reduced Sec62/LC3β co‐localization on ER of isolated hepatocytes from AT‐1 sTg mice. Quantitation of results is shown in (n) (WT, <italic>n</italic> = 5; AT‐1 sTg, <italic>n</italic> = 5). (o, p) Western blot showing co‐immunoprecipitation of Atg9a and Sec62 in WT and AT‐1 sTg mice. Representative blots are shown in (o) while quantitation of results is shown in (p) (WT, <italic>n</italic> = 7; AT‐1 sTg, <italic>n</italic> = 7). Bars represent mean ± <italic>SD</italic>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.005, <sup>#</sup>
<italic>p</italic> &lt; 0.0005. N: nucleus</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="ACEL-17-e12820-g005"></graphic>
</fig>
<p>Previous data in MEF from AT‐1<sup>S113R/+</sup> mice and H4 cells overexpressing AT‐1 indicate that changes in autophagy induction downstream of AT‐1 are also paralleled by changes in efficiency of the secretory pathway; specifically, reduced AT‐1 activity leads to reduced trafficking of newly synthesized glycoproteins along the secretory pathway while increased AT‐1 activity leads to the opposite effect (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>). To test whether this was indeed the case in AT‐1 sTg mice, we used azide‐modified mannosamine (ManNAz) to label sialic acid‐containing newly synthesized glycoproteins that have successfully trafficked from the ER to the <italic>trans</italic>‐Golgi (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>). The results show a significant increase in the levels of ManNAz incorporation in hepatocytes from AT‐1 sTg animals (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S3</xref>c). Therefore, when taken together, the combined use of SP‐A53 T syn and ManNAz confirm the conclusion that changes in reticulophagy in AT‐1 sTg mice are closely paralleled by opposite changes in the transport of cargo proteins along the secretory pathway. These results are in line with previous data (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>).</p>
<p>In addition to reduced elimination of toxic protein aggregates, a significant block in reticulophagy is expected to cause structural reorganization of the organelle. To determine whether this was indeed the case, we used super‐resolution microscopy, specifically structured illumination microscopy (SIM). Consistent with our prediction, we observed a profound reorganization of the ER in AT‐1 sTg; particularly, we observed expansion of the organelle and enlarged sheet‐like structures (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>c and Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S3</xref>d). Even when comparing similar structures in WT and AT‐1 sTg mice, the transgenic animals displayed a marked membrane proliferation with numerous processes emerging from the ER sheets (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>c; discussed later).</p>
</sec>
<sec id="acel12820-sec-0006">
<label>2.4</label>
<title>AT‐1 sTg mice display reduced Atg9a‐Fam134b‐LC3β and Atg9a‐Sec62‐LC3β interaction</title>
<p>The role of Atg9a as a potential “sensor” of the acetylation status of the ER has already been described (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>, <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). Thus, the above results are not surprising. However, what remains to be determined is how the acetylation of Atg9a on K359 and K363 within the lumen of the ER can activate the core of the autophagy machinery, which is mainly cytosolic (Klionsky et al., <xref ref-type="ref" rid="acel12820-bib-0022">2016</xref>). Interestingly, the above two lysine residues are flanked by two coiled regions that could be involved with protein–protein interactions (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>). This might suggest that the acetylation status of Atg9a regulates the interaction with other ER‐luminal or membrane‐bound partners. However, as the core of the autophagy machinery is mainly cytosolic, a membrane‐bound protein is more likely to connect an ER‐luminal event, acetylation of Atg9a, to the autophagy core machinery, specifically LC3β.</p>
<p>To address the above scenario and dissect the mechanism responsible for the block in reticulophagy, we studied levels and ER association of Fam134b, a recently identified key regulator of reticulophagy (Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>). Interestingly, the ER expansion in AT‐1 sTg mice was accompanied by a marked increase in the number of Fam134b puncta on the ER membrane (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>d,e). The upregulation of Fam134b in AT‐1 sTg mice was also observed when we analyzed mRNA (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>f) and protein levels (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>g,h). Fam134b has recently emerged as a novel regulator of ER‐autophagy, and levels of Fam134b seem to reflect intrinsic dynamics of reticulophagy (Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Lennemann &amp; Coyne, <xref ref-type="ref" rid="acel12820-bib-0027">2017</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Nakatogawa &amp; Mochida, <xref ref-type="ref" rid="acel12820-bib-0037">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>). Therefore, increased steady‐state levels of Fam134b in AT‐1 sTg mice (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>d–h) are consistent with the observed ER expansion (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>c and Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S3</xref>d), as they might reflect reduced turnover of the ER‐associated Fam134b protein as well as an attempt of the cell to restore reticulophagy by activating Fam134b translation. Fam134b has a LC3‐interacting region (LIR) on its C‐terminus, which is required for binding to cytosolic LC3β (also referred to as Atg8 in yeast; Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>). Fam134b‐LC3β interaction is required for efficient induction of reticulophagy (Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>). Notably, despite the increased levels of Fam134b, we observed a marked reduction in Fam134b‐LC3β co‐localization in AT‐1 sTg vs. WT (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>i,j).</p>
<p>The finding that AT‐1 sTg mice display less Fam134b‐LC3β interaction led us to hypothesize that Atg9a, which acts as a sensor of ER acetylation (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>), might engage with Fam134b within the ER membrane. Indeed, immunoprecipitation of Atg9a from the ER membrane was able to pull‐down Fam134b (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>k,l); however, this interaction was markedly reduced in AT‐1 sTg mice (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>k,l) suggesting that the increased acetylation of Atg9a (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>a) impedes functional interaction (see also later). The reduced Atg9a‐Fam134b association in AT‐1 sTg mice was observed despite the fact that we consistently pulled down more Atg9a from the ER of the Tg animals compared to WT littermates (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>k) and that Fam134b is upregulated in the Tg animals (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>g; see also later).</p>
<p>Another important regulator of reticulophagy is Sec62, a member of the ER membrane translocon complex, which regulates import of newly synthesized proteins within the ER (Fumagalli et al., <xref ref-type="ref" rid="acel12820-bib-0007">2016</xref>). Like Fam134b, Sec62 also has a LIR domain, which is required for binding to LC3β; increased Sec62‐LC3β interaction promotes reticulophagy and delivery of ER cargo proteins to autolysosomes (Fumagalli et al., <xref ref-type="ref" rid="acel12820-bib-0007">2016</xref>). As with Fam134b, SIM imaging revealed a marked reduction in Sec62‐LC3β co‐localization in AT‐1 sTg vs. WT animals (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>m,n). Furthermore, direct biochemical assessment revealed that Atg9a is able to engage Sec62 at the ER membrane; however, the Atg9a‐Sec62 interaction was greatly reduced in the AT‐1 sTg mice (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>o,p). Again, this was observed even though we pulled down more Atg9a from the ER of the Tg animals (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>o). SIM imaging showed that Fam134b‐LC3β and Sec62‐LC3β co‐localization can be observed on the ER membrane (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S3</xref>e), suggesting that the initial interaction of Fam134b and Sec62 with LC3β can occur on the ER itself prior to the formation of the autophagosome. This process is blocked in AT‐1 sTg mice (Figure <xref ref-type="fig" rid="acel12820-fig-0005">5</xref>i–p).</p>
<p>When taken together, the above results suggest that AT‐1 overexpression and increased cytosol‐to‐ER flux of acetyl‐CoA leads to increased acetylation of Atg9a and reduced Atg9a‐Fam134b and Atg9a‐Sec62 interaction within the ER membrane; this prevents interaction with LC3β, thus causing a block in the induction of reticulophagy. Defective reticulophagy is then accompanied by expansion of the organelle. In essence, the acetylation status of Atg9a appears to regulate Fam134b‐LC3β and Sec62‐LC3β interaction and consequent induction of reticulophagy (also discussed later).</p>
<p>The insulin growth factor 1 (Igf‐1) and its receptor (Igf‐1r; Kenyon, <xref ref-type="ref" rid="acel12820-bib-0019">2005</xref>; Longo &amp; Finch, <xref ref-type="ref" rid="acel12820-bib-0031">2003</xref>; Milman, Huffman, &amp; Barzilai, <xref ref-type="ref" rid="acel12820-bib-0035">2016</xref>), as well as the stemness potential of stem cells (Garcia‐Prat et al., <xref ref-type="ref" rid="acel12820-bib-0008">2016</xref>; Garcia‐Prat, Sousa‐Victor, &amp; Munoz‐Canoves, <xref ref-type="ref" rid="acel12820-bib-0009">2017</xref>), represent already established age‐associated pathways. To determine whether they were mechanistically involved—at least in part—in the AT‐1 sTg phenotype, we analyzed whole tissue activation of Igf‐1r signaling (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S4</xref>a,b); we also treated cultured MEF with Igf‐1 (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S4</xref>c,d). However, we did not observe increased Igf‐1r signaling in AT‐1 sTg mice when compared to WT littermates (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S4</xref>). Similarly, no differences were detected in the percentages of bone marrow Lin<sup>−</sup>Sca<sup>+</sup>c‐Kit<sup>+</sup> (L<sup>−</sup>S<sup>+</sup>K<sup>+</sup>), multipotent progenitor (MPP; L<sup>−</sup>S<sup>+</sup>K<sup>+</sup>,CD48<sup>+</sup>, CD150<sup>−</sup>), long‐term hematopoietic stem cell (HSC; LT‐HSC; L<sup>−</sup>S<sup>+</sup>K<sup>+</sup>,CD48<sup>−</sup>, CD150<sup>+</sup>), or short‐term HSC (ST‐HSC; L<sup>−</sup>S<sup>+</sup>K<sup>+</sup>,CD48<sup>−</sup>, CD150<sup>−</sup>) populations from bone marrow of WT and AT‐1 sTg mice, suggesting no intrinsic block in stemness potential (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S5</xref>a). Next, we transplanted WT and AT‐1 sTg bone marrow (CD45.2) into lethally irradiated recipient mice with CD45.1 spleen cells as a supporting cell population and CD45.1 bone marrow cells. Again, no significant differences in contribution of CD45.2 donor cells to bone marrow were observed in WT vs. AT‐1 sTg transplantation (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S5</xref>b,c).</p>
<p>Many human progeroid syndromes are characterized by nuclear instability where the primary defect is in the architecture and shape of the nuclear envelope; associated animal models reproduce the nuclear instability and mimic the progeroid phenotype (reviewed in Kubben &amp; Misteli, <xref ref-type="ref" rid="acel12820-bib-0025">2017</xref>). However, direct assessment of AT‐1 sTg mice did not reveal any morphological aberration of the nucleus (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S6</xref>).</p>
<p>When taken together, the above results suggest that the reduced Atg9a‐Fam134b‐LC3β and Atg9a‐Sec62‐LC3β interaction, and the consequent block in reticulophagy with changes in efficiency of the secretory pathway are solely responsible for the progeria‐like phenotype of AT‐1 sTg mice.</p>
</sec>
<sec id="acel12820-sec-0007">
<label>2.5</label>
<title>Inhibition of the ATases rescues the AT‐1 sTg phenotype</title>
<p>In addition to AT‐1, which maintains the supply of acetyl‐CoA to the ER lumen, the acetylation machinery includes two acetyltransferases, ATase1 and ATase2, which use acetyl‐CoA to carry out the reaction of Nε‐lysine acetylation (Ko &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0023">2009</xref>). The ATases are ER‐resident membrane proteins and act downstream of AT‐1 (see Figure <xref ref-type="fig" rid="acel12820-fig-0006">6</xref>a). We previously reported the identification of ATase1/ATase2‐specific inhibitors (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0005">2012</xref>); we also reported the successful use of one of these compounds (6‐chloro‐5H‐benzo[a]phenoxazin‐5‐one; referred to as compound 9) in a mouse model of Alzheimer's disease (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). Compound 9 is a powerful inhibitor of both ATases (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0005">2012</xref>); it reduces the acetylation of Atg9a, improves the proteostatic functions of the ER, and is orally absorbed (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). Therefore, we treated AT‐1 sTg mice with oral formulations of the compound (50 mg kg<sup>−1</sup> day<sup>−1</sup>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). We argued that if indeed the AT‐1 sTg phenotype is caused by defective reticulophagy and defective elimination of toxic protein aggregates that form within the ER, then restoring the proteostatic functions of the ER by acting downstream of AT‐1 is expected to ameliorate or rescue the phenotype. As an additional control to this study, we added a group of animals fed a Dox‐containing diet to turn off the expression of AT‐1 itself (see Figure <xref ref-type="fig" rid="acel12820-fig-0001">1</xref>a). In both cases, compound 9 and Dox were administered at weaning (postnatal day 22–25) when the initial disease phenotypes were already manifested.</p>
<fig fig-type="Figure" id="acel12820-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<p>ATase1/ATase2 inhibition rescues the progeria‐like phenotype and lifespan of AT‐1 sTg mice. (a) Schematic view of the ER acetylation machinery with compound 9 acting on the ATases downstream of AT‐1. (b, c) Representative images of AT‐1 sTg mice with and without compound 9 treatment. Dox treatment is shown for comparison. Mice at two different ages are shown. (d) Body weight of male and female AT‐1 sTg mice with and without compound 9 treatment. Dox‐treated AT‐1 sTg mice are shown for comparison (<italic>n</italic> = 16 for all groups). (e) Lifespan of AT‐1 sTg mice with and without compound 9 treatment. Dox‐treated AT‐1 sTg mice are shown for comparison (<italic>p</italic> &lt; 0.0005, all vs. AT‐1 sTg with chow). (f) Postmortem examination of WT and AT‐1 sTg mice treated with compound 9. Dox treatment is shown for comparison. Mice were 8 months old when examined. Bars represent mean ± <italic>SD</italic>. <sup>**</sup>
<italic>p</italic> &lt; 0.005; <sup>#</sup>
<italic>p</italic> &lt; 0.0005</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="ACEL-17-e12820-g006"></graphic>
</fig>
<p>Inhibition of the ATase1 and ATase2 by compound 9 rescued the progeria‐like phenotype of AT‐1 sTg mice. Indeed, the animals looked healthy, did not develop skin lesions, alopecia, rectal prolapse, or lordokyphosis (Figure <xref ref-type="fig" rid="acel12820-fig-0006">6</xref>b,c), and were able to gain weight as a function of age (Figure <xref ref-type="fig" rid="acel12820-fig-0006">6</xref>d). Importantly, compound 9 also rescued the lifespan of the animals (Figure <xref ref-type="fig" rid="acel12820-fig-0006">6</xref>e). Postmortem analysis of 8‐month‐old animals confirmed our general assessment. Compound 9‐treated mice had normal fat pads and did not display muscle atrophy (Figure <xref ref-type="fig" rid="acel12820-fig-0006">6</xref>f). A complete blood count showed no evidence of anemia, which was paralleled by a normal sized spleen and no evidence of extramedullary erythropoiesis (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>a,b). The lymph nodes were overall normal (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>c); this result was paralleled by normalization of circulating inflammatory molecules (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>d) and the absence of SA‐β‐Gal activation (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>e,f). Compound 9‐treated mice also displayed normal bone mineral density (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>g). Finally, compound 9 was able to rescue the metabolic aspects of the AT‐1 sTg phenotype, including food intake (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>h), circulating levels of glucose (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>i), and cholesterolemia (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>j).</p>
<p>Next, we determined Atg9a‐Fam134b interaction as well as levels of Fam134b on ER structures following compound 9 treatment. Again, we observed that AT‐1 sTg mice displayed reduced Atg9a‐Fam134 interaction and increased ER membrane‐associated Fam134b levels; however, both findings were completely normalized by compound 9 treatment (Figure <xref ref-type="fig" rid="acel12820-fig-0007">7</xref>a–d). Indeed, compound 9 restored Atg9a‐Fam134b interaction (Figure <xref ref-type="fig" rid="acel12820-fig-0007">7</xref>a,b) and normalized Fam134b levels (Figure <xref ref-type="fig" rid="acel12820-fig-0007">7</xref>c,d). A similar result was observed with Sec62. In fact, compound 9 restored the Atg9a‐Sec62 interaction at the ER membrane (Figure <xref ref-type="fig" rid="acel12820-fig-0007">7</xref>e,f). Finally, compound 9 rescued the membrane expansion and reorganization of the ER observed in AT‐1 sTg mice (Figure <xref ref-type="fig" rid="acel12820-fig-0007">7</xref>g,h).</p>
<fig fig-type="Figure" id="acel12820-fig-0007" orientation="portrait" position="float" xml:lang="en">
<label>Figure 7</label>
<caption>
<p>ATase1/ATase2 inhibition restores reticulophagy in AT‐1 sTg mice. (a, b) Western blot showing Atg9a‐Fam134b interaction on the ER membrane of compound 9‐treated AT‐1 sTg mice. Dox‐treated and 3‐month‐old AT‐1 sTg mice are shown for comparison. Representative blots are shown in (a) while quantitation of results is shown in (b) (<italic>n</italic> = 6 for all groups). (c, d) Western blot showing ER levels of Fam134b in compound 9‐treated AT‐1 sTg mice. Dox‐treated and 3‐month‐old AT‐1 sTg mice are shown for comparison. Representative blots are shown in (c) while quantitation of results is shown in (d) (<italic>n</italic> = 6 for all groups). (e, f) Western blot showing Atg9a‐Sec62 interaction on the ER membrane of compound 9‐treated AT‐1 sTg mice. Dox‐treated and 3‐month‐old AT‐1 sTg mice are shown for comparison. Representative blots are shown in (e) while quantitation of results is shown in (f) (<italic>n</italic> = 6 for all groups). (g) Structure illumination microscopy (SIM) of ER in isolated hepatocytes from compound 9‐treated AT‐1 sTg mice. Dox‐treated and 3‐month‐old AT‐1 sTg mice are shown for comparison. (h) High‐magnification images with Imaris‐mediated reconstruction. Bars represent mean ± <italic>SD</italic>. <sup>*</sup>
<italic>p</italic> &lt; 0.05, <sup>**</sup>
<italic>p</italic> &lt; 0.005, <sup>#</sup>
<italic>p</italic> &lt; 0.0005. N: nucleus</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="ACEL-17-e12820-g007"></graphic>
</fig>
<p>In conclusion, the above results show that restoring the proteostatic functions of the ER by inhibiting ATase1 and ATase2 downstream of AT‐1 rescues the progeria‐like phenotype of AT‐1 sTg mice; they also support the notion that a block in Atg9a‐Fam134b‐LC3b and Atg9a‐Sec62‐LC3β interaction and the consequent defect in reticulophagy are at the basis of the AT‐1 sTg phenotype (Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S8</xref>). Although with some minor differences, the rescue elicited by compound 9 treatment was overall comparable to that of Dox, which in this study acted as our genetic control (see Figures <xref ref-type="fig" rid="acel12820-fig-0006">6</xref> and <xref ref-type="fig" rid="acel12820-fig-0007">7</xref>; Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S7</xref>). It is also important to stress that for our postmortem analysis, we used 8‐month‐old animals, which corresponds to approximately twice the lifespan of untreated AT‐1 sTg mice, thus indicating that the protective effects of compound 9 were long lasting.</p>
</sec>
</sec>
<sec id="acel12820-sec-0008">
<label>3</label>
<title>DISCUSSION</title>
<sec id="acel12820-sec-0009">
<label>3.1</label>
<title>Increased acetyl‐CoA flux into the ER causes a progeria‐like phenotype</title>
<p>Acetyl‐CoA is a central metabolite that is key to many biochemical and cellular pathways. Acetyl‐CoA also acts as the donor of the acetyl group in all reactions of Nε‐lysine acetylation. Here, we report that increased acetyl‐CoA flux from the cytosol to the ER lumen, as caused by systemic overexpression of human AT‐1 in the mouse, causes a progeria‐like phenotype with metabolic alterations. Segmental progerias typically manifest with severe debilitating symptoms and reduced lifespan. At birth, patients are typically smaller and display facial dysmorphism; as they grow, they develop a complex phenotype that often mimics accelerated forms of pathogenic aging. Segmental progerias include Hutchinson–Gilford, Cokayne, Werner, Bloom, and Rothmund–Thompsons syndromes, among others (Gonzalo et al., <xref ref-type="ref" rid="acel12820-bib-0011">2017</xref>; Karikkineth et al., <xref ref-type="ref" rid="acel12820-bib-0018">2017</xref>; Kubben &amp; Misteli, <xref ref-type="ref" rid="acel12820-bib-0025">2017</xref>; Swahari &amp; Nakamura, <xref ref-type="ref" rid="acel12820-bib-0049">2016</xref>).</p>
<p>Almost all human progeroid syndromes are characterized by nuclear and/or genomic instability where the primary defect is in the architecture of the nuclear envelope or in the DNA repairing machinery; associated animal models reproduce the nuclear and genomic instability and mimic the progeroid phenotype (reviewed in (Kubben &amp; Misteli, <xref ref-type="ref" rid="acel12820-bib-0025">2017</xref>)). Exceptions to the above are the p53/p44 and the AT‐1 sTg systems. In the case of p53/p44, the primary defect is in the N‐terminal regulatory functions of the p53 protein, which leads to reduced stemness potential of stem cells as well as hyperactivation of IGF‐1R signaling (Campisi, <xref ref-type="ref" rid="acel12820-bib-0001">2004</xref>; Lessel et al., <xref ref-type="ref" rid="acel12820-bib-0028">2017</xref>; Maier et al., <xref ref-type="ref" rid="acel12820-bib-0034">2004</xref>; Pehar, Ko, Li, Scrable, &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0040">2014</xref>; Tyner et al., <xref ref-type="ref" rid="acel12820-bib-0052">2002</xref>). AT‐1 sTg mice display many features that are in line with classical segmental progerias, such as reduced growth, alopecia, skin lesions, rectal prolapse, osteoporosis, cardiomegaly, muscle atrophy, reduced fertility, and systemic inflammation. Unlike classical progerias, they do not display nuclear/genomic instability, reduced stemness potential of stem cells, or hyperactivation of IGF‐1R signaling. Also in contrast with classical progerias, AT‐1 sTg mice display metabolic‐linked features that are not typically observed in patients with progeria. We contend that the AT‐1 sTg mouse represents the first model of progeria‐like phenotype where the primary defect is in the regulation of intracellular acetyl‐CoA flux, reticulophagy, and proteostatic functions of the ER. In light of the known association between dysfunctional autophagy and age‐associated diseases (Kroemer, <xref ref-type="ref" rid="acel12820-bib-0024">2015</xref>; Madeo, Tavernarakis, &amp; Kroemer, <xref ref-type="ref" rid="acel12820-bib-0032">2010</xref>; Madeo, Zimmermann, Maiuri, &amp; Kroemer, <xref ref-type="ref" rid="acel12820-bib-0033">2015</xref>), we can speculate that AT‐1 sTg mice will offer new mechanistic and therapeutic avenues for several age‐associated diseases.</p>
</sec>
<sec id="acel12820-sec-0010">
<label>3.2</label>
<title>The progeria‐like phenotype of AT‐1 sTg mice is caused by a block in reticulophagy</title>
<p>Our data suggest that defects in reticulophagy, perhaps accompanied by opposite changes in efficiency of the secretory pathway (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>), may causally contribute to the progeria‐like phenotype of the AT‐1 sTg mice. In AT‐1 sTg mice, reticulophagy is linked to the acetylation status of Atg9a indicating that acetyl‐coA flux is a key input for maintenance of ER homeostatic mechanisms (see Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S8</xref>). We have previously shown that Atg9a acts as a sensor of the ER acetylation machinery; indeed, downregulation or expression of hypomorphic AT‐1 lowers levels of acetylation of Atg9a and induces autophagy, while overexpression of AT‐1 leads to increased acetylation of Atg9a and a block in autophagy induction (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>; Peng &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0044">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). Importantly, gain‐of‐acetylation and loss‐of‐acetylation mutants of Atg9a can recapitulate the events reported above, thus providing mechanistic support (Pehar et al., <xref ref-type="ref" rid="acel12820-bib-0039">2012</xref>).</p>
<p>New results reported in this study indicate that functional Atg9a‐Fam134b and Atg9a‐Sec62 association is an initial and essential step for reticulophagy and that these interactions can occur only when Atg9a is not acetylated, highlighting the importance of acetylation on multiple levels in proteostatic control (see Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S8</xref>). Fam134b is an integral ER membrane protein that acts as a “receptor” for reticulophagy (Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>). It was recently identified in both yeast and mammalian cells (Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>). Interestingly, Fam134b seems to preferentially localize on ER sheet‐like (rough ER) structures, where the bulk of protein biosynthesis normally occurs, and might act as part of quality control to couple protein biosynthesis to disposal of unfolded/misfolded polypeptides (Nakatogawa &amp; Mochida, <xref ref-type="ref" rid="acel12820-bib-0037">2015</xref>). Sec62, an integral member of the ER translocon machinery, also seems to act as an ER‐resident autophagy “receptor” (Fumagalli et al., <xref ref-type="ref" rid="acel12820-bib-0007">2016</xref>). Sec62 is also thought to be involved in coupling the insertion of newly synthesized proteins into the ER with the regulatory mechanisms that detect and dispose of unfolded/misfolded polypeptides (Schuck, <xref ref-type="ref" rid="acel12820-bib-0048">2016</xref>). Both Fam134b and Sec62 require physical interaction with LC3β to exert their functions (Fumagalli et al., <xref ref-type="ref" rid="acel12820-bib-0007">2016</xref>; Khaminets et al., <xref ref-type="ref" rid="acel12820-bib-0020">2015</xref>; Mochida et al., <xref ref-type="ref" rid="acel12820-bib-0036">2015</xref>; Rubinsztein, <xref ref-type="ref" rid="acel12820-bib-0047">2015</xref>; Schuck, <xref ref-type="ref" rid="acel12820-bib-0048">2016</xref>). The fact that Atg9a acetylation status directs the formation of Sec62 and Fam134b complexes, sequestering them from the essential binding partner LC3β, suggests coordination of events to influence reticulophagy (see Supporting Information Figure <xref ref-type="supplementary-material" rid="acel12820-sup-0001">S8</xref>). The specific contribution of enhanced efficiency of the secretory pathway to the progeria phenotype of AT‐1 sTg mice remains to be determined.</p>
</sec>
<sec id="acel12820-sec-0011">
<label>3.3</label>
<title>Biochemical inhibition of the ATases downstream of AT‐1 restores reticulophagy and rescues the progeria‐like phenotype</title>
<p>The impact of pharmacological inhibition of the acetyltransferases, ATase1 and ATase2, is an exciting development and one that may have clinical application. ATase1 and ATase2 act downstream of AT‐1 to acetylate ER cargo proteins (Ko &amp; Puglielli, <xref ref-type="ref" rid="acel12820-bib-0023">2009</xref>), regulate the acetylation status of Atg9a, and are essential for the proteostatic functions of the ER acetylation machinery (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0004">2014</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). Our study showed that inhibition of the ATases was able to restore the Atg9a‐Fam134b‐LC3β and Atg9a‐Sec62‐LC3β interaction at the ER membrane and rescue the progeria‐like phenotype of AT‐1 sTg mice. Overexpression of AT‐1 in the mouse seems to recapitulate the outcomes of children with duplications of the 3q25.31 locus (containing <italic>AT‐1/SLC33A1</italic>). In this study, treatment with compound 9 was initiated at weaning when the disease manifestations were already developing. This suggests that strategies based on similar targeting might be effective in treating the human disease, where early diagnosis and early treatment could mitigate or even prevent disease manifestations.</p>
<p>While recognizing the intrinsic limitations of a single gene‐directed progeria model, several aspects of the phenotype developed by AT‐1 sTg mice mimic accelerated forms of pathogenic aging. Therefore, the model may provide insights into a range of age‐related diseases and conditions, and studies on ATase1/ATase2 inhibitors might be relevant for chronic diseases linked to proteostatic dysfunction. For example, the entire ER acetylation machinery, AT‐1 (Gomez Ravetti, Rosso, Berretta, &amp; Moscato, <xref ref-type="ref" rid="acel12820-bib-0010">2010</xref>; Jonas et al., <xref ref-type="ref" rid="acel12820-bib-0016">2010</xref>) and the ATases (Ding et al., <xref ref-type="ref" rid="acel12820-bib-0005">2012</xref>), is upregulated in patients with late‐onset Alzheimer's disease, the most common form of age‐associated dementia. Importantly, both haploinsufficiency of AT‐1 and biochemical inhibition of the ATases using compound 9 were able to rescue the Alzheimer's disease‐like phenotype in the mouse (Duran‐Aniotz, Cornejo, &amp; Hetz, <xref ref-type="ref" rid="acel12820-bib-0006">2016</xref>; Peng et al., <xref ref-type="ref" rid="acel12820-bib-0042">2016</xref>). We are eager to further explore these models and strategies that we believe will have utility in a broader context of aging and age‐related disease.</p>
</sec>
</sec>
<sec id="acel12820-sec-0012">
<label>4</label>
<title>CONCLUSION</title>
<p>In conclusion, our study shows that systemic overexpression of AT‐1 in the mouse causes a progeria‐like phenotype with metabolic alterations. Mechanistically, the phenotype is caused by a block in Atg9a‐Fam134b‐LC3β and Atg9a‐Sec62‐LC3β interaction, which prevents the induction of reticulophagy. Our study also shows that restoring the proteostatic functions of the ER, by targeting the ATases downstream of AT‐1, can rescue the mouse phenotype, thus suggesting that ATase1/ATase2 inhibitors might offer translational opportunities for patients with <italic>AT‐1/SLC33A1</italic> duplications and for the mitigation of different age‐associated diseases. Finally, this study sets the foundation for new inquiries into the mechanisms that regulate intracellular acetyl‐CoA flux and availability, and how they can influence disease phenotypes that have not been traditionally viewed as primarily driven by metabolic changes.</p>
</sec>
<sec id="acel12820-sec-0013">
<label>5</label>
<title>EXPERIMENTAL PROCEDURES</title>
<sec id="acel12820-sec-0014">
<label>5.1</label>
<title>Transgenic animals</title>
<p>pTRE‐AT‐1 Tg mice were described previously (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>). ROSA:LNL:tTA (Gt(ROSA)26Sor<sup>tm1(tTA)Roos</sup>/J; JAX Stock No: 011008) were bred to EIIa‐Cre (B6.FVB‐Tg(EIIa‐cre)C5379Lmgd/J; JAX Stock No: 003724), generating Rosa26:tTA mice which universally express tTA. Rosa26:tTA mice were then crossed with pTRE‐AT‐1 mice to generate ROSA26:tTA;pTRE‐AT‐1 (referred to as AT‐1 sTg) mice. Genotyping from tail DNA was performed using the following primers: AT‐1 forward (5′‐AAT CTG GGA AAC TGG CCT TCT‐3′), AT‐1 reverse (5′‐TAT TAC CGC CTT TGA GTG AGC TGA‐3′), Rosa forward (5′‐AAA GTC GCT CTG AGT TGT TAT‐3′), and Rosa reverse (5′‐GCG AAG AGT TTG TCC TCA ACC‐3′). Both males and females were studied. Wild‐type (WT) littermates were used as controls throughout our study. Unless specified, living AT‐1 sTg mice were studied at the age of approx. 3 months.</p>
<p>The rodent diet with Compound 9 was manufactured by Bio‐Serv. The food with doxycycline (200 mg/kg) was purchased from Bio‐Serv. The same diet without Compound 9 or doxycycline served as the control diet.</p>
<p>All animal experiments were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Wisconsin‐Madison and the Madison Veterans Administration Hospital.</p>
</sec>
<sec id="acel12820-sec-0015">
<label>5.2</label>
<title>Cell cultures</title>
<p>Mouse embryonic fibroblasts (MEFs) from wild‐type and AT‐1 sTg mice were prepared as described previously (Peng et al., <xref ref-type="ref" rid="acel12820-bib-0043">2014</xref>). Further details are in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0016">
<label>5.3</label>
<title>Hepatocyte isolation</title>
<p>Hepatocytes were isolated and analyzed as described in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0017">
<label>5.4</label>
<title>Protein extraction, western blotting, and immunoprecipitation</title>
<p>Protein extraction, western blotting, and immunoprecipitation techniques are described in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0018">
<label>5.5</label>
<title>Dot blots</title>
<p>Dot blot analysis was performed as described in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0019">
<label>5.6</label>
<title>Real‐time PCR</title>
<p>Real‐time PCR was performed as described before (Jonas et al., <xref ref-type="ref" rid="acel12820-bib-0016">2010</xref>). Further details are in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0020">
<label>5.7</label>
<title>Histology and bone histomorphometry</title>
<p>Histology and bone histomorphometry were performed as described in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0021">
<label>5.8</label>
<title>Faxitron radiography and dual‐energy X‐ray absorptiometry</title>
<p>Dual‐energy X‐ray absorptiometry analysis was conducted as described in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0022">
<label>5.9</label>
<title>Whole blood, serum, and plasma analytes</title>
<p>Blood, serum, and plasma analytes were determined as in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0023">
<label>5.10</label>
<title>Blood and bone marrow smear examination</title>
<p>Fresh whole blood or bone marrow samples were smeared as in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0024">
<label>5.11</label>
<title>Flow cytometry</title>
<p>Flow cytometry was performed as in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0025">
<label>5.12</label>
<title>Erythroid progenitor assays</title>
<p>Erythroid progenitor assays were performed as in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0026">
<label>5.13</label>
<title>Bone marrow transplantation</title>
<p>Bone marrow transplantation experiments were performed as described previously (Wang et al., <xref ref-type="ref" rid="acel12820-bib-0053">2011</xref>). Further details are in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0027">
<label>5.14</label>
<title>Senescence‐associated β‐galactosidase staining</title>
<p>Senescence β‐galactosidase staining was performed as in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0028">
<label>5.15</label>
<title>OGTT, glucose, insulin, and glucagon assays</title>
<p>OGTT, glucose, insulin, and glucagon assays were performed as in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0029">
<label>5.16</label>
<title>Echocardiography</title>
<p>Transthoracic echocardiography was performed as described previously (Harris et al., <xref ref-type="ref" rid="acel12820-bib-0012">2002</xref>). Further details are in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0030">
<label>5.17</label>
<title>Trafficking of newly synthetized glycoproteins</title>
<p>Quantification of trafficking glycoproteins along the secretory pathway was performed as previously described (Hullinger et al., <xref ref-type="ref" rid="acel12820-bib-0013">2016</xref>). Further details are in Supporting Information.</p>
</sec>
<sec id="acel12820-sec-0031">
<label>5.18</label>
<title>Statistics</title>
<p>Data analysis was performed using <sc>graphpad instat</sc> 3.06 statistical software (GraphPad Software Inc.). Data are expressed as mean ± standard deviation (<italic>SD</italic>). Comparison of the means was performed using Student's <italic>t</italic>‐test or one‐way ANOVA followed by Tukey–Kramer multiple comparisons test. For lifespan assessment, data were analyzed with the Kaplan–Meier lifespan test and log‐rank test using <sc>graphpad prism</sc> version 7.03 (GraphPad Software). Differences were declared statistically significant if <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="acel12820-sec-0033">
<title>CONFLICT OF INTEREST</title>
<p>DWL has received funding from, and is a scientific advisory board member of, Delos Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases. DWL's spouse is an employee of DaVita Clinical Research. All others authors have no conflict of interests to disclose.</p>
</sec>
<sec id="acel12820-sec-0032">
<title>
<sc>author contribution</sc>
</title>
<p>YP, SLS, VCB, IAD, KJH, GK, KLS, RS, and SIAA performed experiments and all authors analyzed data. EHB, JZ, MPK, ADA, TAH, EK‐G, DWL, RMA, and LP provided critical advice for the experiments. LP designed the overall study and wrote the manuscript with input from all authors.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="acel12820-sup-0001">
<caption>
<p> </p>
</caption>
<media xlink:href="ACEL-17-e12820-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="acel12820-sec-0035">
<title>ACKNOWLEDGMENTS</title>
<p>We thank Dr. Albee Messing for critical reading of an early version of this manuscript. We thank Dr. Maria M. Mihaylova and Nicole Cummings for advice on hepatocyte isolation and culture; Dr. Peter Muir, Vicki Kalscheur, and Zhengling Hao at the UW Bone Core Facility for their help with bone analysis; Dr. Brigitte Raabe and Yang Pong for their help with the mouse colony. This work was supported by the NIH (NS094154 and AG053937 to LP; AG057408 to LP and RMA; DK50107 to EHB.; HL113066 and CA152108 to JZ; DK102948 and DK108259 to ADA; AG041765 and AG051974 to DWL); a core grant to the Waisman Center from NICHD‐U54 HD090256; the Glenn Foundation to DWL; and the American Federation for Aging Research to DWL. IAD was supported by T32 AG000213. SIAA was supported in part by the American Diabetes Association. This work was also supported using resources and facilities of the William S. Middleton Memorial Veterans Hospital (Madison, WI). SIM imaging was performed at the Biochemistry Optical Core of the University of Wisconsin‐Madison (Madison, WI).</p>
</ack>
<ref-list content-type="cited-references" id="acel12820-bibl-0001">
<title>REFERENCES</title>
<ref id="acel12820-bib-0001">
<mixed-citation id="acel12820-cit-0001" publication-type="journal">
<string-name>
<surname>Campisi</surname>, <given-names>J.</given-names>
</string-name> (<year>2004</year>). <article-title>Fragile fugue: p53 in aging, cancer and IGF signaling</article-title>. <source xml:lang="en"/>Nature Medicine, <volume>10</volume>(<issue>3</issue>), <fpage>231</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1038/nm0304-231</pub-id>
</mixed-citation>
</ref>
<ref id="acel12820-bib-0002">
<mixed-citation id="acel12820-cit-0002" publication-type="journal">
<string-name>
<surname>Chiplunkar</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bindu</surname>, <given-names>P. S.</given-names>
</string-name>, <string-name>
<surname>Nagappa</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bineesh</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Govindaraj</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Gayathri</surname>, <given-names>N.</given-names>
</string-name>, … <string-name>
<surname>Taly</surname>, <given-names>A. B.</given-names>
</string-name> (<year>2016</year>). <article-title>Huppke‐Brendel syndrome in a seven months old boy with a novel 2‐bp deletion in SLC33A1</article-title>. <source xml:lang="en"/>Metabolic Brain Disease, <volume>31</volume>(<issue>5</issue>), <fpage>1195</fpage>–<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-016-9854-6</pub-id>
<pub-id pub-id-type="pmid">27306358</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0004">
<mixed-citation id="acel12820-cit-0004" publication-type="journal">
<string-name>
<surname>Ding</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Dellisanti</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<surname>Ko</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Czajkowski</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2014</year>). <article-title>The endoplasmic reticulum‐based acetyltransferases, ATase1 and ATase2, associate with the oligosaccharyl‐transferase to acetylate correctly folded polypeptides</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>289</volume>(<issue>46</issue>), <fpage>32044</fpage>–<lpage>32055</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.585547</pub-id>
<pub-id pub-id-type="pmid">25301944</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0005">
<mixed-citation id="acel12820-cit-0005" publication-type="journal">
<string-name>
<surname>Ding</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ko</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Pehar</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kotch</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Peters</surname>, <given-names>N. R.</given-names>
</string-name>, <string-name>
<surname>Luo</surname>, <given-names>Y.</given-names>
</string-name>, … <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2012</year>). <article-title>Biochemical inhibition of the acetyltansferases ATase1 and ATase2 reduces b‐secretase (BACE1) levels and Ab generation</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>287</volume>, <fpage>8424</fpage>–<lpage>8433</lpage>.<pub-id pub-id-type="pmid">22267734</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0006">
<mixed-citation id="acel12820-cit-0006" publication-type="journal">
<string-name>
<surname>Duran‐Aniotz</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Cornejo</surname>, <given-names>V. H.</given-names>
</string-name>, &amp; <string-name>
<surname>Hetz</surname>, <given-names>C.</given-names>
</string-name> (<year>2016</year>). <article-title>Targeting endoplasmic reticulum acetylation to restore proteostasis in Alzheimer's disease</article-title>. <source xml:lang="en"/>Brain, <volume>139</volume>(<issue>3</issue>), <fpage>650</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv401</pub-id>
<pub-id pub-id-type="pmid">26917585</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0007">
<mixed-citation id="acel12820-cit-0007" publication-type="journal">
<string-name>
<surname>Fumagalli</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Noack</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Bergmann</surname>, <given-names>T. J.</given-names>
</string-name>, <string-name>
<surname>Cebollero</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Pisoni</surname>, <given-names>G. B.</given-names>
</string-name>, <string-name>
<surname>Fasana</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Molinari</surname>, <given-names>M.</given-names>
</string-name> (<year>2016</year>). <article-title>Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery</article-title>. <source xml:lang="en"/>Nature Cell Biology, <volume>18</volume>(<issue>11</issue>), <fpage>1173</fpage>–<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3423</pub-id>
<pub-id pub-id-type="pmid">27749824</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0008">
<mixed-citation id="acel12820-cit-0008" publication-type="journal">
<string-name>
<surname>Garcia‐Prat</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Martinez‐Vicente</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Perdiguero</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ortet</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Rodriguez‐Ubreva</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Rebollo</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Munoz‐Canoves</surname>, <given-names>P.</given-names>
</string-name> (<year>2016</year>). <article-title>Autophagy maintains stemness by preventing senescence</article-title>. <source xml:lang="en"/>Nature, <volume>529</volume>(<issue>7584</issue>), <fpage>37</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/nature16187</pub-id>
<pub-id pub-id-type="pmid">26738589</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0009">
<mixed-citation id="acel12820-cit-0009" publication-type="journal">
<string-name>
<surname>Garcia‐Prat</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Sousa‐Victor</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Munoz‐Canoves</surname>, <given-names>P.</given-names>
</string-name> (<year>2017</year>). <article-title>Proteostatic and metabolic control of stemness</article-title>. <source xml:lang="en"/>Cell Stem Cell, <volume>20</volume>, <fpage>593</fpage>–<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2017.04.011</pub-id>
<pub-id pub-id-type="pmid">28475885</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0010">
<mixed-citation id="acel12820-cit-0010" publication-type="journal">
<string-name>
<surname>Gomez Ravetti</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rosso</surname>, <given-names>O. A.</given-names>
</string-name>, <string-name>
<surname>Berretta</surname>, <given-names>R.</given-names>
</string-name>, &amp; <string-name>
<surname>Moscato</surname>, <given-names>P.</given-names>
</string-name> (<year>2010</year>). <article-title>Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease</article-title>. <source xml:lang="en"/>PLoS One., <volume>5</volume>(<issue>4</issue>), <fpage>e10153</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010153</pub-id>
<pub-id pub-id-type="pmid">20405009</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0011">
<mixed-citation id="acel12820-cit-0011" publication-type="journal">
<string-name>
<surname>Gonzalo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kreienkamp</surname>, <given-names>R.</given-names>
</string-name>, &amp; <string-name>
<surname>Askjaer</surname>, <given-names>P.</given-names>
</string-name> (<year>2017</year>). <article-title>Hutchinson‐Gilford progeria syndrome: A premature aging disease caused by LMNA gene mutations</article-title>. <source xml:lang="en"/>Ageing Research Reviews, <volume>33</volume>, <fpage>18</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2016.06.007</pub-id>
<pub-id pub-id-type="pmid">27374873</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0012">
<mixed-citation id="acel12820-cit-0012" publication-type="journal">
<string-name>
<surname>Harris</surname>, <given-names>S. P.</given-names>
</string-name>, <string-name>
<surname>Bartley</surname>, <given-names>C. R.</given-names>
</string-name>, <string-name>
<surname>Hacker</surname>, <given-names>T. A.</given-names>
</string-name>, <string-name>
<surname>McDonald</surname>, <given-names>K. S.</given-names>
</string-name>, <string-name>
<surname>Douglas</surname>, <given-names>P. S.</given-names>
</string-name>, <string-name>
<surname>Greaser</surname>, <given-names>M. L.</given-names>
</string-name>, … <string-name>
<surname>Moss</surname>, <given-names>R. L.</given-names>
</string-name> (<year>2002</year>). <article-title>Hypertrophic cardiomyopathy in cardiac myosin binding protein‐C knockout mice</article-title>. <source xml:lang="en"/>Circulation Research, <volume>90</volume>(<issue>5</issue>), <fpage>594</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.0000012222.70819.64</pub-id>
<pub-id pub-id-type="pmid">11909824</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0013">
<mixed-citation id="acel12820-cit-0013" publication-type="journal">
<string-name>
<surname>Hullinger</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Peng</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Dowell</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Bomba‐Warczak</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2016</year>). <article-title>Increased expression of AT‐1/SLC33A1 causes an autistic‐like phenotype in mice by affecting dendritic branching and spine formation</article-title>. <source xml:lang="en"/>Journal of Experimental Medicine, <volume>213</volume>(<issue>7</issue>), <fpage>1267</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151776</pub-id>
<pub-id pub-id-type="pmid">27242167</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0014">
<mixed-citation id="acel12820-cit-0014" publication-type="journal">
<string-name>
<surname>Huppke</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Brendel</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Kalscheuer</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Korenke</surname>, <given-names>G. C.</given-names>
</string-name>, <string-name>
<surname>Marquardt</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Freisinger</surname>, <given-names>P.</given-names>
</string-name>, … <string-name>
<surname>Gartner</surname>, <given-names>J.</given-names>
</string-name> (<year>2012</year>). <article-title>Mutations in SLC33A1 cause a lethal autosomal‐recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>90</volume>(<issue>1</issue>), <fpage>61</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.030</pub-id>
<pub-id pub-id-type="pmid">22243965</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0015">
<mixed-citation id="acel12820-cit-0015" publication-type="journal">
<string-name>
<surname>Jeon</surname>, <given-names>O. H.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Laberge</surname>, <given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Demaria</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rathod</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Vasserot</surname>, <given-names>A. P.</given-names>
</string-name>, … <string-name>
<surname>Elisseeff</surname>, <given-names>J. H.</given-names>
</string-name> (<year>2017</year>). <article-title>Local clearance of senescent cells attenuates the development of post‐traumatic osteoarthritis and creates a pro‐regenerative environment</article-title>. <source xml:lang="en"/>Nature Medicine, <volume>23</volume>(<issue>6</issue>), <fpage>775</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4324</pub-id>
</mixed-citation>
</ref>
<ref id="acel12820-bib-0016">
<mixed-citation id="acel12820-cit-0016" publication-type="journal">
<string-name>
<surname>Jonas</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Pehar</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2010</year>). <article-title>AT‐1 is the ER membrane acetyl‐CoA transporter and is essential for cell viability</article-title>. <source xml:lang="en"/>Journal of Cell Science, <volume>123</volume>(<issue>19</issue>), <fpage>3378</fpage>–<lpage>3388</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.068841</pub-id>
<pub-id pub-id-type="pmid">20826464</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0017">
<mixed-citation id="acel12820-cit-0017" publication-type="journal">
<string-name>
<surname>Kang</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>T. D.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>M. Z.</given-names>
</string-name>, <string-name>
<surname>Demaria</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Aron</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Elledge</surname>, <given-names>S. J.</given-names>
</string-name> (<year>2015</year>). <article-title>The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4</article-title>. <source xml:lang="en"/>Science, <volume>349</volume>(<issue>6255</issue>), <fpage>aaa5612</fpage>
<pub-id pub-id-type="doi">10.1126/science.aaa5612</pub-id>
<pub-id pub-id-type="pmid">26404840</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0018">
<mixed-citation id="acel12820-cit-0018" publication-type="journal">
<string-name>
<surname>Karikkineth</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Scheibye‐Knudsen</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Fivenson</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Croteau</surname>, <given-names>D. L.</given-names>
</string-name>, &amp; <string-name>
<surname>Bohr</surname>, <given-names>V. A.</given-names>
</string-name> (<year>2017</year>). <article-title>Cockayne syndrome: Clinical features, model systems and pathways</article-title>. <source xml:lang="en"/>Ageing Research Reviews, <volume>33</volume>, <fpage>3</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2016.08.002</pub-id>
<pub-id pub-id-type="pmid">27507608</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0019">
<mixed-citation id="acel12820-cit-0019" publication-type="journal">
<string-name>
<surname>Kenyon</surname>, <given-names>C.</given-names>
</string-name> (<year>2005</year>). <article-title>The plasticity of aging: Insights from long‐lived mutants</article-title>. <source xml:lang="en"/>Cell, <volume>120</volume>(<issue>4</issue>), <fpage>449</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.02.002</pub-id>
<pub-id pub-id-type="pmid">15734678</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0020">
<mixed-citation id="acel12820-cit-0020" publication-type="journal">
<string-name>
<surname>Khaminets</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Heinrich</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Mari</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Grumati</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Huebner</surname>, <given-names>A. K.</given-names>
</string-name>, <string-name>
<surname>Akutsu</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Dikic</surname>, <given-names>I.</given-names>
</string-name> (<year>2015</year>). <article-title>Regulation of endoplasmic reticulum turnover by selective autophagy</article-title>. <source xml:lang="en"/>Nature, <volume>522</volume>(<issue>7556</issue>), <fpage>354</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1038/nature14498</pub-id>
<pub-id pub-id-type="pmid">26040720</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0022">
<mixed-citation id="acel12820-cit-0022" publication-type="journal">
<string-name>
<surname>Klionsky</surname>, <given-names>D. J.</given-names>
</string-name>, <string-name>
<surname>Abdelmohsen</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Abe</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Abedin</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Abeliovich</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Acevedo Arozena</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Zughaier</surname>, <given-names>S. M.</given-names>
</string-name> (<year>2016</year>). <article-title>Guidelines for the use and interpretation of assays for monitoring autophagy</article-title>. <source xml:lang="en"/>Autophagy, <volume>12</volume>(<issue>1</issue>), <fpage>1</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2015.1100356</pub-id>
<pub-id pub-id-type="pmid">26799652</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0023">
<mixed-citation id="acel12820-cit-0023" publication-type="journal">
<string-name>
<surname>Ko</surname>, <given-names>M. H.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2009</year>). <article-title>Two endoplasmic reticulum (ER)/ER golgi intermediate compartment‐based lysine acetyltransferases post‐translationally regulate BACE1 levels</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>284</volume>(<issue>4</issue>), <fpage>2482</fpage>–<lpage>2492</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M804901200</pub-id>
<pub-id pub-id-type="pmid">19011241</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0024">
<mixed-citation id="acel12820-cit-0024" publication-type="journal">
<string-name>
<surname>Kroemer</surname>, <given-names>G.</given-names>
</string-name> (<year>2015</year>). <article-title>Autophagy: A druggable process that is deregulated in aging and human disease</article-title>. <source xml:lang="en"/>Journal of Clinical Investigation, <volume>125</volume>(<issue>1</issue>), <fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1172/JCI78652</pub-id>
<pub-id pub-id-type="pmid">25654544</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0025">
<mixed-citation id="acel12820-cit-0025" publication-type="journal">
<string-name>
<surname>Kubben</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Misteli</surname>, <given-names>T.</given-names>
</string-name> (<year>2017</year>). <article-title>Shared molecular and cellular mechanisms of premature ageing and ageing‐associated diseases</article-title>. <source xml:lang="en"/>Nature Reviews Molecular Cell Biology, <volume>18</volume>(<issue>10</issue>), <fpage>595</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.68</pub-id>
<pub-id pub-id-type="pmid">28792007</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0027">
<mixed-citation id="acel12820-cit-0027" publication-type="journal">
<string-name>
<surname>Lennemann</surname>, <given-names>N. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Coyne</surname>, <given-names>C. B.</given-names>
</string-name> (<year>2017</year>). <article-title>Dengue and Zika viruses subvert reticulophagy by NS2B3‐mediated cleavage of FAM134B</article-title>. <source xml:lang="en"/>Autophagy, <volume>13</volume>(<issue>2</issue>), <fpage>322</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2016.1265192</pub-id>
<pub-id pub-id-type="pmid">28102736</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0028">
<mixed-citation id="acel12820-cit-0028" publication-type="journal">
<string-name>
<surname>Lessel</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Trujillo</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Ramezani</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Lessel</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Alwasiyah</surname>, <given-names>M. K.</given-names>
</string-name>, … <string-name>
<surname>Kubisch</surname>, <given-names>C.</given-names>
</string-name> (<year>2017</year>). <article-title>Dysfunction of the MDM2/p53 axis is linked to premature aging</article-title>. <source xml:lang="en"/>Journal of Clinical Investigation, <volume>127</volume>(<issue>10</issue>), <fpage>3598</fpage>–<lpage>3608</lpage>. <pub-id pub-id-type="doi">10.1172/JCI92171</pub-id>
<pub-id pub-id-type="pmid">28846075</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0029">
<mixed-citation id="acel12820-cit-0029" publication-type="journal">
<string-name>
<surname>Liao</surname>, <given-names>C. Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Kennedy</surname>, <given-names>B. K.</given-names>
</string-name> (<year>2014</year>). <article-title>Mouse models and aging: Longevity and progeria</article-title>. <source xml:lang="en"/>Current Topics in Developmental Biology, <volume>109</volume>, <fpage>249</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">24947239</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0030">
<mixed-citation id="acel12820-cit-0030" publication-type="journal">
<string-name>
<surname>Lin</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Mao</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Hu</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Gong</surname>, <given-names>Y.</given-names>
</string-name> (<year>2008</year>). <article-title>A missense mutation in SLC33A1, which encodes the acetyl‐CoA transporter, causes autosomal‐dominant spastic paraplegia (SPG42)</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>83</volume>(<issue>6</issue>), <fpage>752</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.11.003</pub-id>
<pub-id pub-id-type="pmid">19061983</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0031">
<mixed-citation id="acel12820-cit-0031" publication-type="journal">
<string-name>
<surname>Longo</surname>, <given-names>V. D.</given-names>
</string-name>, &amp; <string-name>
<surname>Finch</surname>, <given-names>C. E.</given-names>
</string-name> (<year>2003</year>). <article-title>Evolutionary medicine: From dwarf model systems to healthy centenarians?</article-title>
<source xml:lang="en"/>Science, <volume>299</volume>(<issue>5611</issue>), <fpage>1342</fpage>–<lpage>1346</lpage>. <pub-id pub-id-type="doi">10.1126/science.1077991</pub-id>
<pub-id pub-id-type="pmid">12610293</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0032">
<mixed-citation id="acel12820-cit-0032" publication-type="journal">
<string-name>
<surname>Madeo</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Tavernarakis</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Kroemer</surname>, <given-names>G.</given-names>
</string-name> (<year>2010</year>). <article-title>Can autophagy promote longevity?</article-title>
<source xml:lang="en"/>Nature Cell Biology, <volume>12</volume>, <fpage>842</fpage>–<lpage>846</lpage>.<pub-id pub-id-type="pmid">20811357</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0033">
<mixed-citation id="acel12820-cit-0033" publication-type="journal">
<string-name>
<surname>Madeo</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Zimmermann</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Maiuri</surname>, <given-names>M. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Kroemer</surname>, <given-names>G.</given-names>
</string-name> (<year>2015</year>). <article-title>Essential role for autophagy in life span extension</article-title>. <source xml:lang="en"/>Journal of Clinical Investigation, <volume>125</volume>(<issue>1</issue>), <fpage>85</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1172/JCI73946</pub-id>
<pub-id pub-id-type="pmid">25654554</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0034">
<mixed-citation id="acel12820-cit-0034" publication-type="journal">
<string-name>
<surname>Maier</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Gluba</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Bernier</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Turner</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Mohammad</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Guise</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>Scrable</surname>, <given-names>H.</given-names>
</string-name> (<year>2004</year>). <article-title>Modulation of mammalian life span by the short isoform of p53</article-title>. <source xml:lang="en"/>Genes and Development, <volume>18</volume>(<issue>3</issue>), <fpage>306</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1162404</pub-id>
<pub-id pub-id-type="pmid">14871929</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0035">
<mixed-citation id="acel12820-cit-0035" publication-type="journal">
<string-name>
<surname>Milman</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Huffman</surname>, <given-names>D. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Barzilai</surname>, <given-names>N.</given-names>
</string-name> (<year>2016</year>). <article-title>The somatotropic axis in human aging: Framework for the current state of knowledge and future research</article-title>. <source xml:lang="en"/>Cell Metabolism, <volume>23</volume>(<issue>6</issue>), <fpage>980</fpage>–<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.05.014</pub-id>
<pub-id pub-id-type="pmid">27304500</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0036">
<mixed-citation id="acel12820-cit-0036" publication-type="journal">
<string-name>
<surname>Mochida</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Oikawa</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kirisako</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Ohsumi</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Nakatogawa</surname>, <given-names>H.</given-names>
</string-name> (<year>2015</year>). <article-title>Receptor‐mediated selective autophagy degrades the endoplasmic reticulum and the nucleus</article-title>. <source xml:lang="en"/>Nature, <volume>522</volume>(<issue>7556</issue>), <fpage>359</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1038/nature14506</pub-id>
<pub-id pub-id-type="pmid">26040717</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0037">
<mixed-citation id="acel12820-cit-0037" publication-type="journal">
<string-name>
<surname>Nakatogawa</surname>, <given-names>H.</given-names>
</string-name>, &amp; <string-name>
<surname>Mochida</surname>, <given-names>K.</given-names>
</string-name> (<year>2015</year>). <article-title>Reticulophagy and nucleophagy: New findings and unsolved issues</article-title>. <source xml:lang="en"/>Autophagy, <volume>11</volume>(<issue>12</issue>), <fpage>2377</fpage>–<lpage>2378</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2015.1106665</pub-id>
<pub-id pub-id-type="pmid">26566146</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0038">
<mixed-citation id="acel12820-cit-0038" publication-type="journal">
<string-name>
<surname>Ovadya</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Krizhanovsky</surname>, <given-names>V.</given-names>
</string-name> (<year>2014</year>). <article-title>Senescent cells: SASPected drivers of age‐related pathologies</article-title>. <source xml:lang="en"/>Biogerontology, <volume>15</volume>(<issue>6</issue>), <fpage>627</fpage>–<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-014-9529-9</pub-id>
<pub-id pub-id-type="pmid">25217383</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0039">
<mixed-citation id="acel12820-cit-0039" publication-type="journal">
<string-name>
<surname>Pehar</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Jonas</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Hare</surname>, <given-names>T. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2012</year>). <article-title>SLC33A1/AT‐1 protein regulates the induction of autophagy downstream of IRE1/XBP1 pathway</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>287</volume>(<issue>35</issue>), <fpage>29921</fpage>–<lpage>29930</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.363911</pub-id>
<pub-id pub-id-type="pmid">22787145</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0040">
<mixed-citation id="acel12820-cit-0040" publication-type="journal">
<string-name>
<surname>Pehar</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ko</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Scrable</surname>, <given-names>H.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2014</year>). <article-title>P44, the 'longevity‐assurance' isoform of P53, regulates tau phosphorylation and is activated in an age‐dependent fashion</article-title>. <source xml:lang="en"/>Aging Cell, <volume>13</volume>(<issue>3</issue>), <fpage>449</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12192</pub-id>
<pub-id pub-id-type="pmid">24341977</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0042">
<mixed-citation id="acel12820-cit-0042" publication-type="journal">
<string-name>
<surname>Peng</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Hullinger</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>O'Riordan</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Burger</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Pehar</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2016</year>). <article-title>Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse</article-title>. <source xml:lang="en"/>Brain, <volume>139</volume>(<issue>3</issue>), <fpage>937</fpage>–<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv385</pub-id>
<pub-id pub-id-type="pmid">26787453</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0043">
<mixed-citation id="acel12820-cit-0043" publication-type="journal">
<string-name>
<surname>Peng</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Clarkson</surname>, <given-names>B. D.</given-names>
</string-name>, <string-name>
<surname>Pehar</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Lao</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Hillmer</surname>, <given-names>A. T.</given-names>
</string-name>, … <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2014</year>). <article-title>Deficient import of acetyl‐CoA into the ER lumen causes neurodegeneration and propensity to infections, inflammation, and cancer</article-title>. <source xml:lang="en"/>Journal of Neuroscience, <volume>34</volume>(<issue>20</issue>), <fpage>6772</fpage>–<lpage>6789</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0077-14.2014</pub-id>
<pub-id pub-id-type="pmid">24828632</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0044">
<mixed-citation id="acel12820-cit-0044" publication-type="journal">
<string-name>
<surname>Peng</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Puglielli</surname>, <given-names>L.</given-names>
</string-name> (<year>2016</year>). <article-title>N‐lysine acetylation in the lumen of the endoplasmic reticulum: A way to regulate autophagy and maintain protein homeostasis in the secretory pathway</article-title>. <source xml:lang="en"/>Autophagy, <volume>12</volume>, <fpage>1051</fpage>–<lpage>1052</lpage>.<pub-id pub-id-type="pmid">27124586</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0045">
<mixed-citation id="acel12820-cit-0045" publication-type="journal">
<string-name>
<surname>Pivnick</surname>, <given-names>E. K.</given-names>
</string-name>, <string-name>
<surname>Angle</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Kaufman</surname>, <given-names>R. A.</given-names>
</string-name>, <string-name>
<surname>Hall</surname>, <given-names>B. D.</given-names>
</string-name>, <string-name>
<surname>Pitukcheewanont</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Hersh</surname>, <given-names>J. H.</given-names>
</string-name>, … <string-name>
<surname>Ward</surname>, <given-names>J. C.</given-names>
</string-name> (<year>2000</year>). <article-title>Neonatal progeroid (Wiedemann‐Rautenstrauch) syndrome: Report of five new cases and review</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics, <volume>90</volume>(<issue>2</issue>), <fpage>131</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(20000117)90:2aabbb131:AID-AJMG9aaabb3.0.CO;2-E</pub-id>
<pub-id pub-id-type="pmid">10607952</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0046">
<mixed-citation id="acel12820-cit-0046" publication-type="journal">
<string-name>
<surname>Polymeropoulos</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Lavedan</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Leroy</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ide</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Dehejia</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Dutra</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Nussbaum</surname>, <given-names>R. L.</given-names>
</string-name> (<year>1997</year>). <article-title>Mutation in the alpha‐synuclein gene identified in families with Parkinson's disease</article-title>. <source xml:lang="en"/>Science, <volume>276</volume>, <fpage>2045</fpage>–<lpage>2047</lpage>.<pub-id pub-id-type="pmid">9197268</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0047">
<mixed-citation id="acel12820-cit-0047" publication-type="journal">
<string-name>
<surname>Rubinsztein</surname>, <given-names>D. C.</given-names>
</string-name> (<year>2015</year>). <article-title>Cell biology: Receptors for selective recycling</article-title>. <source xml:lang="en"/>Nature, <volume>522</volume>(<issue>7556</issue>), <fpage>291</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1038/nature14532</pub-id>
<pub-id pub-id-type="pmid">26040721</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0048">
<mixed-citation id="acel12820-cit-0048" publication-type="journal">
<string-name>
<surname>Schuck</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>On keeping the right ER size</article-title>. <source xml:lang="en"/>Nature Cell Biology, <volume>18</volume>(<issue>11</issue>), <fpage>1118</fpage>–<lpage>1119</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3430</pub-id>
<pub-id pub-id-type="pmid">27784902</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0049">
<mixed-citation id="acel12820-cit-0049" publication-type="journal">
<string-name>
<surname>Swahari</surname>, <given-names>V.</given-names>
</string-name>, &amp; <string-name>
<surname>Nakamura</surname>, <given-names>A.</given-names>
</string-name> (<year>2016</year>). <article-title>Speeding up the clock: The past, present and future of progeria</article-title>. <source xml:lang="en"/>Development, Growth and Differentiation, <volume>58</volume>, <fpage>116</fpage>–<lpage>130</lpage>.</mixed-citation>
</ref>
<ref id="acel12820-bib-0050">
<mixed-citation id="acel12820-cit-0050" publication-type="journal">
<string-name>
<surname>Tchkonia</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>van Deursen</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Campisi</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Kirkland</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2013</year>). <article-title>Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities</article-title>. <source xml:lang="en"/>Journal of Clinical Investigation, <volume>123</volume>(<issue>3</issue>), <fpage>966</fpage>–<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1172/JCI64098</pub-id>
<pub-id pub-id-type="pmid">23454759</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0052">
<mixed-citation id="acel12820-cit-0052" publication-type="journal">
<string-name>
<surname>Tyner</surname>, <given-names>S. D.</given-names>
</string-name>, <string-name>
<surname>Venkatachalam</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Choi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Jones</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ghebranious</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Igelmann</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Donehower</surname>, <given-names>L. A.</given-names>
</string-name> (<year>2002</year>). <article-title>p53 mutant mice that display early ageing‐associated phenotypes</article-title>. <source xml:lang="en"/>Nature(<issue>6867</issue>), <volume>415</volume>, <fpage>45</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/415045a</pub-id>
<pub-id pub-id-type="pmid">11780111</pub-id></mixed-citation>
</ref>
<ref id="acel12820-bib-0053">
<mixed-citation id="acel12820-cit-0053" publication-type="journal">
<string-name>
<surname>Wang</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Tan</surname>, <given-names>L. X.</given-names>
</string-name>, <string-name>
<surname>Ryu</surname>, <given-names>M. J.</given-names>
</string-name>, … <string-name>
<surname>Zhang</surname>, <given-names>J.</given-names>
</string-name> (<year>2011</year>). <article-title>Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose‐ and cell type‐dependent manner</article-title>. <source xml:lang="en"/>Blood, <volume>118</volume>(<issue>2</issue>), <fpage>368</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2010-12-326058</pub-id>
<pub-id pub-id-type="pmid">21586752</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>